Treanor JJ - Search Results

1

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

Treanor JJ, Wilkinson BE, Masseoud F, Hu-Primmer J, Battaglia R, O'Brien D, Wolff M, Rabinovich G, Blackwelder W, Katz JM. Treanor JJ, et al. Vaccine. 2001 Feb 8;19(13-14):1732-7. doi: 10.1016/s0264-410x(00)00395-9. Vaccine. 2001. PMID: 11166898 Clinical Trial.

2

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M. Treanor JJ, et al. N Engl J Med. 2006 Mar 30;354(13):1343-51. doi: 10.1056/NEJMoa055778. N Engl J Med. 2006. PMID: 16571878 Free article. Clinical Trial.

3

Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults.

Treanor JJ, Betts RF, Smith GE, Anderson EL, Hackett CS, Wilkinson BE, Belshe RB, Powers DC. Treanor JJ, et al. J Infect Dis. 1996 Jun;173(6):1467-70. doi: 10.1093/infdis/173.6.1467. J Infect Dis. 1996. PMID: 8648221 Clinical Trial.

4

Treanor JJ, Schiff GM, Couch RB, Cate TR, Brady RC, Hay CM, Wolff M, She D, Cox MM. Treanor JJ, et al. J Infect Dis. 2006 May 1;193(9):1223-8. doi: 10.1086/503050. Epub 2006 Mar 28. J Infect Dis. 2006. PMID: 16586358 Clinical Trial.

5

Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults.

Treanor JJ, Taylor DN, Tussey L, Hay C, Nolan C, Fitzgerald T, Liu G, Kavita U, Song L, Dark I, Shaw A. Treanor JJ, et al. Vaccine. 2010 Dec 6;28(52):8268-74. doi: 10.1016/j.vaccine.2010.10.009. Epub 2010 Oct 20. Vaccine. 2010. PMID: 20969925 Clinical Trial.

6

Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: a randomized, placebo-controlled trial.

Treanor JJ, El Sahly H, King J, Graham I, Izikson R, Kohberger R, Patriarca P, Cox M. Treanor JJ, et al. Vaccine. 2011 Oct 13;29(44):7733-9. doi: 10.1016/j.vaccine.2011.07.128. Epub 2011 Aug 9. Vaccine. 2011. PMID: 21835220 Clinical Trial.

7

Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant.

Treanor JJ, Essink B, Hull S, Reed S, Izikson R, Patriarca P, Goldenthal KL, Kohberger R, Dunkle LM. Treanor JJ, et al. Vaccine. 2013 Nov 19;31(48):5760-5. doi: 10.1016/j.vaccine.2013.08.064. Epub 2013 Sep 27. Vaccine. 2013. PMID: 24075920 Clinical Trial.

8

Stable emulsion (SE) alone is an effective adjuvant for a recombinant, baculovirus-expressed H5 influenza vaccine in healthy adults: A Phase 2 trial.

Treanor JJ, Chu L, Essink B, Muse D, El Sahly HM, Izikson R, Goldenthal KL, Patriarca P, Dunkle LM. Treanor JJ, et al. Vaccine. 2017 Feb 7;35(6):923-928. doi: 10.1016/j.vaccine.2016.12.053. Epub 2017 Jan 11. Vaccine. 2017. PMID: 28089141 Clinical Trial.

9

Evaluation of the genetic stability of the temperature-sensitive PB2 gene mutation of the influenza A/Ann Arbor/6/60 cold-adapted vaccine virus.

Treanor J, Perkins M, Battaglia R, Murphy BR. Treanor J, et al. J Virol. 1994 Dec;68(12):7684-8. doi: 10.1128/JVI.68.12.7684-7688.1994. J Virol. 1994. PMID: 7966557 Free PMC article.

10

Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant.

Goji NA, Nolan C, Hill H, Wolff M, Noah DL, Williams TB, Rowe T, Treanor JJ. Goji NA, et al. Among authors: treanor jj. J Infect Dis. 2008 Sep 1;198(5):635-41. doi: 10.1086/590916. J Infect Dis. 2008. PMID: 18694338 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

213 results

Search Page